Checkpoint Therapeutics (CKPT)
(Delayed Data from NSDQ)
$2.41 USD
-0.02 (-0.82%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $2.41 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.51 |
EPS Last Quarter | -0.18 |
Last EPS Surprise | 37.93% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.81 |
Next Year | 0.11 |
EPS (TTM) | -1.90 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.03M | 0.01M | 0.10M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.51 | -0.16 | -0.81 | 0.11 |
# of Estimates | 1 | 1 | 2 | 1 |
Most Recent Consensus | -0.51 | -0.16 | -0.80 | NA |
High Estimate | -0.51 | -0.16 | -0.80 | 0.11 |
Low Estimate | -0.51 | -0.16 | -0.81 | 0.11 |
Year ago EPS | -0.29 | -1.10 | -3.17 | -0.81 |
Year over Year Growth Est. | -75.86% | 85.45% | 74.45% | 112.96% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.51 | -0.16 | -0.81 | 0.11 |
7 Days Ago | -0.51 | -0.16 | -0.81 | 0.11 |
30 Days Ago | -0.51 | -0.16 | -0.81 | 0.11 |
60 Days Ago | -0.30 | -0.32 | -1.24 | 0.04 |
90 Days Ago | -0.30 | -0.32 | -1.29 | 0.04 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.51 | -0.16 | -0.81 | 0.11 |
Zacks Consensus Estimate | -0.51 | -0.16 | -0.81 | 0.11 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.18 | -0.33 | -1.10 | -0.29 | NA |
Estimate | -0.29 | -0.37 | -0.74 | -0.85 | NA |
Difference | 0.11 | 0.04 | -0.36 | 0.56 | 0.09 |
Surprise | 37.93% | 10.81% | -48.65% | 65.88% | 16.49% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more